Jump to navigation
INAPPROPRIATE further investigation after normal colonoscopy could have cost as much as $25 million in the first few years of the National Bowel Cancer Screening Program (NBCSP), research suggests.
If you have an account select Login. If you are new to Medical Observer select Join.
Niamh Mullen is a medical writer and former news director of MO.
More articles by this author >
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.